Back
SpringWorks Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
39
SWTX
SpringWorks Therapeutics
Last Price:
$37.10
Seasonality Move:
4.38%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
The current trend is relatively stagnant and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SpringWorks Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.68 | Buy |
| 20-day SMA: | 39.35 | Sell |
| 50-day SMA: | 35.6 | Buy |
| 200-day SMA: | 38.94 | Sell |
| 8-day EMA: | 37.14 | Sell |
| 20-day EMA: | 37.81 | Sell |
| 50-day EMA: | 36.89 | Buy |
| 200-day EMA: | 36.9 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 47.7 | Sell |
| Chaikin Money Flow: | 274650 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.83 - 41.59) | Sell |
| Bollinger Bands (100): | (31.81 - 39.75) | Buy |
SpringWorks Therapeutics Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 37.14 while SWTX 8-day simple moving average is 36.68, which is a Buy signal.
-
The stock price of SWTX is 37.14 while SpringWorks Therapeutics 20-day SMA is 39.35, which makes it a Sell.
-
SpringWorks Therapeutics 50-day simple moving average is 35.60 while SWTX share price is 37.14, making it a Buy technically.
-
SWTX stock price is 37.14 and SpringWorks Therapeutics 200-day simple moving average is 38.94, creating a Sell signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
39
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $37.14. The Score for SWTX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
2.8B
Price in USD:
37.14
Share Volume:
463K
SpringWorks Therapeutics 52-Week Range
52-Week High:
53.92
52-Week Low:
28.21
Sell
39
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 37.14 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 37.14 while SWTX 8-day exponential moving average is 37.14, which is a Sell signal.
-
The stock price of SWTX is 37.14 while SpringWorks Therapeutics 20-day EMA is 37.81, which makes it a Sell.
-
SpringWorks Therapeutics 50-day exponential moving average is 36.89 while SWTX share price is 37.14, making it a Buy technically.
-
SWTX stock price is 37.14 and SpringWorks Therapeutics 200-day simple moving average is 36.90, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $1.22 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting SpringWorks Therapeutics is a Sell
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 47.7, which suggest SpringWorks Therapeutics is oversold
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (36.83 - 41.59), which suggest SpringWorks Therapeutics is a Buy
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (31.81 - 39.75), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.